# PRD: Biomarker Validation Workflow

## Overview

**Product:** Genesee - Biomarker Evidence Synthesis Tool
**Company:** Genesee Sciences
**Target User:** Translational cancer researchers in biotech/pharma
**First User:** Dr. Jianhui Ma, BeOne Medicines

---

## The Job to Be Done

> "Help me build a compelling evidence package for a candidate biomarker so I can convince the clinical biomarker team to run validation experiments."

| State       | Experience                                                             |
| ----------- | ---------------------------------------------------------------------- |
| **Current** | 6+ browser tabs, manual copy-paste, hours of work â†’ PPT                |
| **Desired** | Input biomarker â†’ structured investigation â†’ presentation-ready output |

---

## Problem Statement

When a translational researcher identifies a candidate biomarker (gene, mutation, protein), they must manually investigate its validity across 6+ fragmented data sources before presenting a recommendation to the clinical biomarker team.

**Current workflow pain points:**

- 6+ browser tabs open simultaneously
- Manual searches across PubMed, ClinicalTrials.gov, FDA, COSMIC, cBioPortal, KEGG, etc.
- Copy-paste evidence into PowerPoint slides
- No structured framework - easy to miss important sources
- Time-consuming: hours per biomarker candidate
- Difficult to compare multiple candidates systematically

**Consequence:** Slow decision-making, inconsistent evidence quality, researcher frustration.

---

## Solution

An AI-powered tool that takes a candidate biomarker as input and produces a structured evidence synthesis ready for presentation and team discussion.

**One sentence:** "From candidate biomarker to evidence-backed presentation in minutes, not hours."

---

## Target User Profile

| Attribute | Description                                                                                                        |
| --------- | ------------------------------------------------------------------------------------------------------------------ |
| Role      | Translational researcher, Principal Scientist, Research Director                                                   |
| Domain    | Oncology / Cancer biology                                                                                          |
| Education | PhD or MD/PhD in molecular biology, cell biology, or related                                                       |
| Context   | Biotech or pharma company with clinical development pipeline                                                       |
| Workflow  | Identifies targets/biomarkers â†’ builds evidence case â†’ hands off to clinical biomarker team for validation studies |

**Key insight:** The user is not running the experiments. They are building the scientific rationale for _why_ the biomarker team should invest resources in validation.

---

## Core Workflow

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  INPUT                                                          â”‚
â”‚  â”€â”€â”€â”€â”€                                                          â”‚
â”‚  â€¢ Biomarker (gene symbol, mutation, protein)                   â”‚
â”‚  â€¢ Cancer type / indication (e.g., NSCLC, GBM, breast)         â”‚
â”‚  â€¢ Optional: specific hypothesis or context                     â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                              â”‚
                              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  INVESTIGATION ENGINE                                           â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                           â”‚
â”‚  Parallel queries across:                                       â”‚
â”‚  1. Literature (PubMed) - publications, reviews, meta-analyses  â”‚
â”‚  2. Clinical trials (ClinicalTrials.gov) - active/completed     â”‚
â”‚  3. FDA (companion diagnostics, approvals)                      â”‚
â”‚  4. Mutation databases (COSMIC, cBioPortal) - frequencies       â”‚
â”‚  5. Pathway databases (KEGG, Reactome) - mechanism context      â”‚
â”‚  6. Commercial assays - available validated kits                â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                              â”‚
                              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  SYNTHESIS & SCORING                                            â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€                                            â”‚
â”‚  â€¢ Evidence strength assessment                                 â”‚
â”‚  â€¢ Gap identification (what's missing?)                         â”‚
â”‚  â€¢ Conflict detection (contradictory findings)                  â”‚
â”‚  â€¢ Recommendation generation                                    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                              â”‚
                              â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  OUTPUT                                                         â”‚
â”‚  â”€â”€â”€â”€â”€â”€                                                         â”‚
â”‚  â€¢ Structured report (markdown)                                 â”‚
â”‚  â€¢ Presentation-ready slides (PPT export)                       â”‚
â”‚  â€¢ Evidence table with citations                                â”‚
â”‚  â€¢ Recommended next steps for validation team                   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Data Sources (MVP)

| Source                 | Data Type                          | Access Method                 |
| ---------------------- | ---------------------------------- | ----------------------------- |
| **PubMed**             | Publications, abstracts            | NCBI E-utilities API          |
| **ClinicalTrials.gov** | Trial protocols, status            | ClinicalTrials.gov API        |
| **FDA**                | Companion diagnostics, drug labels | FDA API / web scrape          |
| **COSMIC**             | Somatic mutation frequencies       | COSMIC API (requires license) |
| **cBioPortal**         | Cancer genomics data               | cBioPortal API (open)         |
| **KEGG**               | Pathway maps                       | KEGG API                      |
| **Reactome**           | Pathway data                       | Reactome API                  |

**MVP priority:** PubMed + ClinicalTrials.gov + cBioPortal (all open access)

---

## Output Specification

### Structured Report Sections

1. **Executive Summary**

   - Biomarker overview (gene function, known roles)
   - Evidence strength score (Strong / Moderate / Weak / Insufficient)
   - Key finding highlights
   - Recommendation

2. **Literature Evidence**

   - Key publications (ranked by relevance)
   - Publication trends (is interest growing?)
   - Notable authors/institutions

3. **Clinical Evidence**

   - Trials using this biomarker (as inclusion criteria, endpoint, or stratification)
   - Trial phases and status
   - Sponsor companies (competitive landscape)

4. **Genomic Evidence**

   - Mutation frequency in target cancer type
   - Co-occurring mutations
   - Comparison across cancer types

5. **Regulatory Status**

   - FDA-approved companion diagnostics
   - Relevant drug approvals mentioning this biomarker

6. **Pathway Context**

   - Signaling pathway membership
   - Upstream/downstream relationships
   - Druggable nodes in pathway

7. **Evidence Gaps**

   - What data is missing?
   - Suggested validation experiments

8. **References**
   - Full citation list with links

---

## User Experience

### Core Concept: Claude Code for Biomedical Research

The model is **agentic chat**, not forms. Like Claude Code, but specialized for life sciences:

- Run `genesee` in a project directory
- Chat naturally about your research
- Tools get called automatically (PubMed, trials, genomics, etc.)
- Results appear in a rich TUI
- You decide what to keep

### Project Structure

Researchers have multiple ongoing projects, each with subprojects:

```
~/research/
â”œâ”€â”€ egfr-nsclc-study/           â† run `genesee` here
â”‚   â”œâ”€â”€ literature/
â”‚   â”œâ”€â”€ biomarkers/
â”‚   â”œâ”€â”€ notes.md
â”‚   â””â”€â”€ .genesee/            â† project state/history
â”‚       â”œâ”€â”€ history.json
â”‚       â”œâ”€â”€ cache/
â”‚       â””â”€â”€ lancedb/            â† vector embeddings
â”œâ”€â”€ pten-gbm-resistance/
â””â”€â”€ ctdna-monitoring-panel/
```

Each directory is a project context. Genesee scans files, builds a tree, understands what you're working on.

### Launch

```bash
$ cd ~/research/egfr-nsclc-study
$ genesee
```

### TUI Layout

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚  ğŸ§¬ Genesee                                          egfr-nsclc-study       â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¬â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚                        â”‚                                                    â”‚
â”‚  ğŸ“ Project Files      â”‚  Chat                                              â”‚
â”‚  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€    â”‚  â”€â”€â”€â”€                                              â”‚
â”‚  â–¼ egfr-nsclc-study    â”‚                                                    â”‚
â”‚    â–¼ literature/       â”‚  You: What's the mutation frequency of EGFR in     â”‚
â”‚      review-2024.pdf   â”‚       NSCLC patients?                              â”‚
â”‚      key-papers.md     â”‚                                                    â”‚
â”‚    â–¼ biomarkers/       â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚      candidates.csv    â”‚  â”‚ ğŸ”§ Tool: cBioPortal                         â”‚   â”‚
â”‚    notes.md            â”‚  â”‚ Querying EGFR mutations in lung cancer...   â”‚   â”‚
â”‚                        â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â”‚                        â”‚                                                    â”‚
â”‚                        â”‚  Genesee: Based on cBioPortal data, EGFR mutations   â”‚
â”‚                        â”‚  occur in approximately 15-20% of NSCLC cases.     â”‚
â”‚                        â”‚                                                    â”‚
â”‚                        â”‚  The most common mutations are:                    â”‚
â”‚                        â”‚  â€¢ Exon 19 deletions (45%)                         â”‚
â”‚                        â”‚  â€¢ L858R point mutation (40%)                      â”‚
â”‚                        â”‚  â€¢ T790M (acquired resistance)                     â”‚
â”‚                        â”‚                                                    â”‚
â”‚                        â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”                 â”‚
â”‚                        â”‚  â”‚ ğŸ’¾ Save      â”‚ â”‚ ğŸ“‹ Copy      â”‚                 â”‚
â”‚                        â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜                 â”‚
â”‚                        â”‚                                                    â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚  > Ask anything about your research...                                      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Agentic Workflow

User asks naturally, tools are called as needed:

```
You: Find recent clinical trials for EGFR inhibitors in NSCLC

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ”§ Tool: ClinicalTrials.gov                                 â”‚
â”‚ Searching: EGFR inhibitor AND NSCLC, Phase 2-3, 2023-2024   â”‚
â”‚ Found: 47 trials                                            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜

Genesee: I found 47 recent trials. Here are the most relevant:

1. **NCT05774951** - Osimertinib + Chemotherapy (Phase 3)
   Sponsor: AstraZeneca | Status: Recruiting

2. **NCT05504044** - Amivantamab + Lazertinib (Phase 3)
   Sponsor: Janssen | Status: Active

3. **NCT05388669** - CLN-081 for EGFR Exon 20 (Phase 2)
   Sponsor: Cullinan | Status: Recruiting

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â” â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ’¾ Save All  â”‚ â”‚ ğŸ“Š Export    â”‚ â”‚ ğŸ” Show More (44)    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜ â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Tool Results are Interactive

When tools return results, the user can:

- **Save** â€” add to project files
- **Copy** â€” to clipboard
- **Export** â€” to markdown, CSV, or PPT
- **Discard** â€” don't keep this result
- **Refine** â€” ask follow-up questions

### Subagents (MVP)

These aren't simple function calls â€” they're **specialized subagents** that can reason, make multiple API calls, and synthesize results. Like Claude Code's Task tool spawning agents.

| Subagent     | Capability                                                                                          |
| ------------ | --------------------------------------------------------------------------------------------------- |
| `literature` | Searches PubMed + Semantic Scholar, filters by relevance, summarizes key findings, tracks citations |
| `trials`     | Queries ClinicalTrials.gov, understands phases/status, identifies competitors                       |
| `genomics`   | Queries cBioPortal, interprets mutation frequencies, finds co-occurring alterations                 |
| `chemistry`  | Queries PubChem/ChEMBL, retrieves compound structures, drug properties, ADMET data                  |
| `files`      | Reads/writes project files, understands context from existing documents                             |
| `synthesize` | Combines information from multiple sources into coherent summaries                                  |

Each subagent:

- Understands natural language intent
- Makes multiple API calls if needed
- Filters and ranks results
- Returns structured, actionable output

### Context Awareness

Genesee understands project context:

```
You: What biomarkers should I add to this panel?

Genesee: Based on your project files, you're studying EGFR resistance
in NSCLC. Looking at candidates.csv, you already have:
- EGFR (primary)
- KRAS (exclusion)
- T790M (resistance)

Let me search for commonly co-occurring mutations...

â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ ğŸ”§ Tool: cBioPortal                                         â”‚
â”‚ Querying co-mutations with EGFR in lung adenocarcinoma...   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Navigation

- **Type** â€” chat naturally
- **â†‘/â†“** â€” scroll through history
- **Tab** â€” switch between file tree and chat
- **Enter** â€” send message / confirm action
- **Esc** â€” cancel current operation
- **Ctrl+S** â€” save current results

---

## MVP Scope

### In Scope (V1)

- **TUI with agentic chat** (just run `genesee`)
- **Project awareness** â€” scans directory, builds file tree, understands context
- **Natural language input** â€” ask questions, get answers
- **Core subagents:**
  - `literature` â€” PubMed search, filtering, summarization
  - `trials` â€” ClinicalTrials.gov search, parsing, ranking
  - `genomics` â€” cBioPortal queries, interpretation
  - `chemistry` â€” PubChem/ChEMBL, compound data, drug properties
  - `files` â€” read/write project files, context extraction
- **Interactive results** â€” save, copy, export, discard
- **Conversation history** â€” persisted in `.genesee/`
- **Markdown export**

### Out of Scope (V1)

- PPT export (Phase 2)
- COSMIC integration (requires license)
- FDA database integration (complex scraping)
- Pathway visualization
- Multi-project dashboard
- Team collaboration features

---

## Success Metrics

| Metric                         | Target                                     |
| ------------------------------ | ------------------------------------------ |
| Time to first investigation    | < 1 minute from launch (no learning curve) |
| Time to complete investigation | < 10 minutes (vs. hours)                   |
| Data sources covered           | 3+ per query                               |
| User satisfaction (first user) | "I would use this daily"                   |
| Zero confusion                 | No "how do I...?" questions                |
| Output usability               | Directly usable in team meeting            |

---

## Technical Architecture

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                      TUI Interface                          â”‚
â”‚                       (Textual)                             â”‚
â”‚  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”  â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”‚
â”‚  â”‚  File Tree   â”‚  â”‚  Chat Panel                        â”‚   â”‚
â”‚  â”‚  (project)   â”‚  â”‚  (conversation + subagent results) â”‚   â”‚
â”‚  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜  â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â”‚
                            â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                   Orchestrator Agent                        â”‚
â”‚      Understands intent, spawns subagents, synthesizes      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â”‚
      â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¼â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
      â–¼                     â–¼                     â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”   â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚literature â”‚   â”‚  trials   â”‚   â”‚ genomics  â”‚   â”‚ chemistry â”‚
â”‚           â”‚   â”‚           â”‚   â”‚           â”‚   â”‚           â”‚
â”‚ â€¢ PubMed  â”‚   â”‚ â€¢ CTgov   â”‚   â”‚â€¢ cBioPortalâ”‚  â”‚ â€¢ PubChem â”‚
â”‚ â€¢ filter  â”‚   â”‚ â€¢ parse   â”‚   â”‚â€¢ interpretâ”‚   â”‚ â€¢ ChEMBL  â”‚
â”‚ â€¢ summary â”‚   â”‚ â€¢ rank    â”‚   â”‚â€¢ correlateâ”‚   â”‚ â€¢ ADMET   â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜   â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
      â”‚               â”‚               â”‚               â”‚
      â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â”‚
              â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
              â–¼                           â–¼
       â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”             â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
       â”‚    files    â”‚             â”‚  synthesize â”‚
       â”‚             â”‚             â”‚             â”‚
       â”‚ â€¢ read      â”‚             â”‚ â€¢ combine   â”‚
       â”‚ â€¢ write     â”‚             â”‚ â€¢ cite      â”‚
       â”‚ â€¢ context   â”‚             â”‚ â€¢ conclude  â”‚
       â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜             â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â”‚
                            â–¼
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚                   Project State                              â”‚
â”‚  .genesee/history.json  â€” conversation history           â”‚
â”‚  .genesee/cache/        â€” cached API responses           â”‚
â”‚  .genesee/lancedb/      â€” vector embeddings (LanceDB)    â”‚
â”‚  project files             â€” user's research documents      â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

---

## Existing Components (from genesee-desktop)

The `genesee-desktop` PySide6 project has reusable backend components:

| Module                       | Description                                | Reuse                                       |
| ---------------------------- | ------------------------------------------ | ------------------------------------------- |
| `search/pubmed.py`           | PubMed E-utilities API client, XML parsing | âœ… Direct                                   |
| `search/semantic_scholar.py` | Semantic Scholar API client                | âœ… Direct                                   |
| `search/arxiv.py`            | ArXiv search client                        | âœ… Direct                                   |
| `search/vector_search.py`    | Vector/semantic search                     | ğŸ”„ Rewrite with LanceDB                     |
| `ai/providers.py`            | Anthropic, OpenAI, Ollama abstraction      | âœ… Direct                                   |
| `ai/embeddings.py`           | Embedding generation                       | âœ… Direct                                   |
| `core/document.py`           | Document model with sources, chunking      | âœ… Direct                                   |
| `core/pdf_processor.py`      | PDF text extraction                        | âœ… Direct                                   |
| `core/database.py`           | SQLite for document metadata               | ğŸ”„ Adapt (metadata only, vectors â†’ LanceDB) |
| `ui/*`                       | PySide6 widgets                            | âŒ Replace with Textual                     |

**Strategy:** Extract the `search/`, `ai/`, and `core/` modules into a shared package, then build TUI on top.

---

## Open Questions

1. **Authentication:** Do we need user accounts, or is this a local-first tool?
2. **Data freshness:** Cache results? How long?
3. **LLM choice:** Claude API for synthesis? Local model option?
4. **PPT templates:** Should we allow custom branding/templates?
5. **Validation team handoff:** Any integration with lab systems?

---

## Roadmap (Features, not timeline)

### Phase 1: Agentic Chat Foundation

- TUI with file tree + chat panel
- Orchestrator agent + subagent architecture
- Core subagents: `literature`, `trials`, `genomics`, `chemistry`, `files`
- Project directory scanning and context
- Conversation history persistence
- Interactive results (save, copy, discard)

### Phase 2: Enhanced Output & Export

- PPT export with professional template
- Structured report generation
- Evidence strength scoring
- Gap analysis summaries

### Phase 3: Extended Data Sources

- COSMIC integration
- FDA companion diagnostics
- KEGG/Reactome pathways
- UniProt protein data

### Phase 4: Deeper Context Awareness

- Parse and understand PDFs in project
- Cross-reference project files with external data
- Smart suggestions based on project state

### Phase 5: Multi-Project & Collaboration

- Project dashboard (switch between projects)
- Shareable reports
- Team annotations
- Integration with internal knowledge bases

---

## Appendix: Competitive Landscape

| Tool                   | Strength                       | Weakness                                  |
| ---------------------- | ------------------------------ | ----------------------------------------- |
| **Manual research**    | Flexible, trusted              | Slow, inconsistent                        |
| **Ingenuity (QIAGEN)** | Comprehensive pathway analysis | Expensive, complex, not biomarker-focused |
| **cBioPortal**         | Great genomic data             | No synthesis, no literature               |
| **PubMed**             | Authoritative literature       | No structure, manual work                 |
| **ChatGPT/Claude**     | Fast synthesis                 | No real-time data, hallucination risk     |
| **Claude Code**        | Agentic, project-aware, tools  | Built for software, not life sciences     |

**Our positioning:** Claude Code for biomedical research.

**Our differentiator:**

- Real-time data from authoritative biomedical sources (PubMed, trials, genomics)
- AI synthesis with citations
- Project-aware context
- Specialized tools for life sciences workflows
- Rich TUI designed for non-developers
